Toggle light / dark theme

Arm thinks those kinds of applications may not be far away, though. In a paper published last week in Nature, researchers from the company detailed a 32-bit microprocessor built directly onto a plastic substrate that promises to be both flexible and dramatically cheaper than today’s chips.

“We envisage that PlasticARM will pioneer the development of low-cost, fully flexible smart integrated systems to enable an ‘internet of everything’ consisting of the integration of more than a trillion inanimate objects over the next decade into the digital world,” they wrote.

Flexible electronics aren’t exactly new, and sensors, batteries, LEDs, antennae, and many other simpler components have all been demonstrated before. But a practical microprocessor that can carry out meaningful computations has been elusive thanks to the large number of transistors required, say the researchers.

More TAME! The first part of this has a lot of result data.


Foresight Biotech & Health Extension Meeting sponsored by 100 Plus Capital.
2021 program & apply to join: https://foresight.org/biotech-health-extension-program/

Nir Barzilai, Albert Einstein School of Medicine.
TAME Q&A: Lessons for Progress on Aging.

About Nir Barzilai:
Nir Barzilai, MD, is a Professor in the Department of Endocrinology Medicine and the Department of Genetics at the Albert Einstein College of Medicine. He is also the Ingeborg and Ira Leon Rennert Chair of Aging Research at the Albert Einstein College of Medicine. Dr. Barzilai is the founding director of the Institute for Aging Research at Albert Einstein College of Medicine and the Director of the Nathan Shock Center for Excellence in the Basic Biology of Aging, funded by the National Institutes of Health (NIH); the center is coordinating 80 investigators and six program projects on the biology of aging. He is also the director of the Glenn Center of Excellence in the Biology of Human Aging. He is a chaired professor of medicine and of genetics and a member of the Diabetes Research Center and the divisions of endocrinology and geriatrics. Dr. Barzilai’s interests focus on several basic mechanisms in the biology of aging, including the biological effects of nutrients on extending life and the genetic determinants of life span. His team discovered many longevity gene in humans, and they further characterized the phenotype and genotype of humans with exceptional longevity through NIH awards. He also has an NIH Merit award investigating the metabolic decline that accompanies aging and its impact on longevity. Dr. Barzilai has published more than 270 peer-reviewed papers, reviews and chapters in textbooks. Dr. Barzilai serves on several editorial boards and advisory boards of pharmaceutical and start-up companies, and is a reviewer for numerous journals. A Beeson Fellow for Aging Research, Dr. Barzilai has received many other prestigious awards, including the Senior Ellison Foundation Award, the 2010 Irving S. Wright Award of Distinction in Aging Research, the NIA–Nathan Shock Award and a merit award from the NIA for his contributions in elucidating metabolic and genetic mechanisms of aging and was the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) Trial, a multi-center study to prove the concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. He is a founder of CohBar Inc. (now public company) and Medical Advisor for Life Biosciences. He is on the board of AFAR and a founding member of the Academy for Lifespan and Healthspan. He has been featured in major papers, TV programs, and documentaries (TEDx and TEDMED) and has been consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, several International Banks, The Vatican, Pepsico, Milkin Institute, The Economist and Wired Magazine. His book, Age Later: Health Span, Life Span, and the New Science of Longevity, was published by St. Martin’s Press in June of 2020.

Zoom Transcription: https://otter.ai/u/0bz5o2crLQncfxlUkctY6NVzcCg.

“It’s an extraordinary paper with some extraordinary claims,” says Gray Camp, a developmental biologist at the University of Basel in Switzerland, whose lab last year reported2 growing brain organoids that contained a gene common to Neanderthals and humans. The latest work takes the research further by looking at gene variants that humans lost in evolution. But Camp remains sceptical about the implications of the results, and says the work opens more questions that will require investigation.

Humans are more closely related to Neanderthals and Denisovans than to any living primate, and some 40% of the Neanderthal genome can still be found spread throughout living humans. But researchers have limited means to study these ancient species’ brains — soft tissue is not well preserved, and most studies rely on inspecting the size and shape of fossilized skulls. Knowing how the species’ genes differ from humans’ is important because it helps researchers to understand what makes humans unique — especially in our brains.

The researchers, led by Alysson Muotri, a neuroscientist at the University of California, San Diego, used the genome-editing technique CRISPR–Cas9 to introduce the Neanderthal and Denisovan form of a gene called NOVA1 into human pluripotent stem cells, which can develop into any cell type. They cultured these to form organoids, clumps of brain-like tissue, up to 5 millimetres across, alongside normal human brain organoids for comparison.

On August 26, 2020, NASA’s Fermi Gamma-ray Space Telescope detected a pulse of high-energy radiation that had been racing toward Earth for nearly half the present age of the universe. Lasting only about a second, it turned out to be one for the record books – the shortest gamma-ray burst (GRB) caused by the death of a massive star ever seen.

GRBs are the most powerful events in the universe, detectable across billions of light-years. Astronomers classify them as long or short based on whether the event lasts for more or less than two seconds. They observe long bursts in association with the demise of massive stars, while short bursts have been linked to a different scenario.

Astronomers combined data from NASA’s Fermi Gamma-ray Space Telescope, other space missions, and ground-based observatories to reveal the origin of GRB 200826A, a brief but powerful burst of radiation. It’s the shortest burst known to be powered by a collapsing star – and almost didn’t happen at all. Credit: NASA’s Goddard Space Flight Center.

Russia has unveiled the Sukhoi Checkmate, a new fifth-generation fighter jet intended to supplement the Su-57 and conquer the international market.

A mockup of the aircraft was presented in a grand ceremony on the opening day of the MAKS airshow in Moscow on July 20, 2021.

“We have been working on the project for just slightly longer than one year. Such a fast development cycle was possible only with the help of advanced computer technologies and virtual testing,” Yuri Slyusar, CEO of United Aircraft Corporation (UAC), said at the event.

Now businesses, start-ups and their backers are eyeing an even bigger bonanza in the form of the next generation of seniors. The market opportunities will shift to the development of products and services through a greater adoption of emerging technology to provide preventive health care, and help people to live in their homes for longer, plus increase independence and well being.


Opportunities in China’s elderly health care will shift to the development of tech-based products and services to help people live longer in their homes and increase their independence and well being.